W

Gastrointestinal Stromal Tumors (GIST) and Resistance Mutations

By Warren Chow
0 views
March 20, 2024
Comments 0
Login to view comments. Click here to Login

Recommended

AUTOPLAY
22:07
Total Health

2024 Update in Sarcomas

Feat. D. Portnoy
22:27
2024 ASCO® Annual Meeting Insights Hub

Developmental Therapeutics Highlights From ASCO® 2024

Feat. G. Sonpavde
18:46
OncoAlert

Systemic Therapies for Uterine Leiomyosarcoma

Feat. I. Ray-Coquard
25:23
Andrea Napolitano

NCCN Clinical Practice Guidelines for Treating GIST

21:12
ISCO - International School of Clinical Oncology

What Is New in Treatment of Soft Tissue and Bone Sarcoma

Feat. S. Stacchiotti
25:02
Total Health

Sarcoma 101: Multidisciplinary Approach, Therapies, and Future Direc…

Feat. B. Wilky
15:45
i3 Health

Multidisciplinary Management of Advanced Soft Tissue Sarcoma

Feat. S. Patel, B. Ruben, K. Polson
10:55
Insights from 2023 ESMO Annual Meeting

ESMO 2023 Insights: "Novel Combinations in Sarcomas"

Feat. R. Jones
16:37
2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 Highlights in Sarcomas

Feat. R. Jones
22:21
Miami Cancer Institute Precision Oncology Symposium

Divide and Conquer Sarcomas Through Precision Oncology

Feat. N. Somaiah
18:44
2023 West Oncology Conference

2023 West Oncology Conference: Soft Tissue Sarcoma Updates

Feat. B. Van Tine
10:48
Insights from 2024 ASCO® GI Annual Meeting

INSIGHT: A Phase 3 Study of Ripretinib vs. Sunitinib in Pts With Adv…

Feat. J. Zalcberg
09:02
Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Insights: "A Phase II Basket Trial of Dual Anti-CTLA…

Feat. Y. Chae
56:31
Fred Hutch 13th Annual Comprehensive Hematology & Oncology Review Course

Fred Hutchinson Cancer Center Sarcoma Updates

Feat. M. Wagner
04:54
2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 Insights: "PROs of the MEDISARC Study (AIO-STS-0415)…

Feat. V. Grünwald
07:29
Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Insights: "Randomized Phase 2 Trial in Metastatic So…

Feat. B. Van Tine
12:08
University of Miami Sylvester Comprehensive Cancer Center

Active Surveillance vs. Active Treatment for Desmoid Tumor: An Exper…

Feat. G. D'Amato
07:00
Insights from 2024 ESMO Sarcoma and Rare Cancers Congress

ctDNA Analysis From INTRIGUE Study: Updated OS & Safety With Rip…

Feat. J. Blay
11:03
Insights from 2024 ASCO® GI Annual Meeting

Final Analyses From INTRIGUE: OS & Long-Term Safety With Ripreti…

Feat. J. Zalcberg
13:53
Robin Jones

Desmoid Tumors: Who, When, and How to Treat?